Results
20,958 records
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 13 | Friedman Paul ADirector |  MDGLMADRIGAL PHARMACEUTICALS, INC.Open-market sale · 10b5-1 plan | SELL | $79K 148 sh | Jan 13, 2026 traded Jan 9, 2026 | |
Congress trades and big insider sales, sent the day they're filed. Free.
Open in TelegramEvery ingested record across SEC Form 4, 13F, House PTRs and Robinhood Chain, searchable by ticker, name or wallet address.
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 13 | Friedman Paul ADirector | MDGLMADRIGAL PHARMACEUTICALS, INC. Open-market sale · 10b5-1 plan | SELL | $79K 148 sh | Jan 13, 2026 traded Jan 9, 2026 | |
Friedman Paul ADirector |
| MDGLMADRIGAL PHARMACEUTICALS, INC. Open-market sale · 10b5-1 plan |
| SELL |
| $177K 332 sh |
| Jan 13, 2026 traded Jan 9, 2026 |
| 13 | Taub RebeccaDirector | MDGLMADRIGAL PHARMACEUTICALS, INC. Open-market sale · 10b5-1 plan | SELL | $229K 440 sh | Jan 13, 2026 traded Jan 9, 2026 |
| 13 | Taub RebeccaDirector | MDGLMADRIGAL PHARMACEUTICALS, INC. Open-market sale · 10b5-1 plan | SELL | $246K 465 sh | Jan 13, 2026 traded Jan 9, 2026 |
| 13 | Taub RebeccaDirector | MDGLMADRIGAL PHARMACEUTICALS, INC. Open-market sale · 10b5-1 plan | SELL | $136K 256 sh | Jan 13, 2026 traded Jan 9, 2026 |
| 13 | Taub RebeccaDirector | MDGLMADRIGAL PHARMACEUTICALS, INC. Open-market sale · 10b5-1 plan | SELL | $145K 271 sh | Jan 13, 2026 traded Jan 9, 2026 |
| 13 | Taub RebeccaDirector | MDGLMADRIGAL PHARMACEUTICALS, INC. Open-market sale · 10b5-1 plan | SELL | $216K 400 sh | Jan 13, 2026 traded Jan 9, 2026 |
| 13 | Friedman Paul ADirector | MDGLMADRIGAL PHARMACEUTICALS, INC. Open-market sale · 10b5-1 plan | SELL | $88K 166 sh | Jan 13, 2026 traded Jan 9, 2026 |
| 11 | Congleton JonDirector, Chief Executive Officer |  MLYSMineralys Therapeutics, Inc.Open-market sale · 10b5-1 plan | SELL | $236K 7,117 sh | Jan 13, 2026 traded Jan 12, 2026 |
| 11 | McCarthy Brian K.Pres.,Global Sales & Field Ops |  RBRKRubrik, Inc.Open-market sale · 10b5-1 plan | SELL | $140K 2,000 sh | Jan 13, 2026 traded Jan 12, 2026 |
| 11 | Baig SaqibChief Accounting Officer |  PTONPELOTON INTERACTIVE, INC.Open-market sale · 10b5-1 plan | SELL | $35K 5,000 sh | Jan 13, 2026 traded Jan 9, 2026 |
| 10 | Thygesen Allan C.Director, President and CEO |  DOCUDOCUSIGN, INC.Open-market sale · 10b5-1 plan | SELL | $21K 300 sh | Jan 13, 2026 traded Jan 9, 2026 |
| 10 | Taub RebeccaDirector | MDGLMADRIGAL PHARMACEUTICALS, INC. Open-market sale · 10b5-1 plan | SELL | $48K 89 sh | Jan 13, 2026 traded Jan 9, 2026 |
| 10 | Taub RebeccaDirector | MDGLMADRIGAL PHARMACEUTICALS, INC. Open-market sale · 10b5-1 plan | SELL | $22K 40 sh | Jan 13, 2026 traded Jan 9, 2026 |
| 10 | Taub RebeccaDirector | MDGLMADRIGAL PHARMACEUTICALS, INC. Open-market sale · 10b5-1 plan | SELL | $22K 40 sh | Jan 13, 2026 traded Jan 9, 2026 |
| 10 | Taub RebeccaDirector | MDGLMADRIGAL PHARMACEUTICALS, INC. Open-market sale · 10b5-1 plan | SELL | $21K 40 sh | Jan 13, 2026 traded Jan 9, 2026 |
| 10 | Taub RebeccaDirector | MDGLMADRIGAL PHARMACEUTICALS, INC. Open-market sale · 10b5-1 plan | SELL | $16K 30 sh | Jan 13, 2026 traded Jan 9, 2026 |
| 10 | Taub RebeccaDirector | MDGLMADRIGAL PHARMACEUTICALS, INC. Open-market sale · 10b5-1 plan | SELL | $22K 40 sh | Jan 13, 2026 traded Jan 9, 2026 |
| 10 | Friedman Paul ADirector | MDGLMADRIGAL PHARMACEUTICALS, INC. Open-market sale · 10b5-1 plan | SELL | $43K 80 sh | Jan 13, 2026 traded Jan 9, 2026 |
| 10 | Friedman Paul ADirector | MDGLMADRIGAL PHARMACEUTICALS, INC. Open-market sale · 10b5-1 plan | SELL | $22K 40 sh | Jan 13, 2026 traded Jan 9, 2026 |
| 10 | Friedman Paul ADirector | MDGLMADRIGAL PHARMACEUTICALS, INC. Open-market sale · 10b5-1 plan | SELL | $43K 80 sh | Jan 13, 2026 traded Jan 9, 2026 |
| 9 |  Farquhar ScottDirector, 10% Owner |  TEAMAtlassian CorpOpen-market sale · 10b5-1 plan | SELL | $481K 3,264 sh | Jan 13, 2026 traded Jan 12, 2026 |
| 9 | Cannon-Brookes MichaelDirector, CEO, Co-Founder, 10% Owner | TEAMAtlassian Corp Open-market sale · 10b5-1 plan | SELL | $344K 2,347 sh | Jan 13, 2026 traded Jan 12, 2026 |
| 9 | Farquhar ScottDirector, 10% Owner | TEAMAtlassian Corp Open-market sale · 10b5-1 plan | SELL | $344K 2,347 sh | Jan 13, 2026 traded Jan 12, 2026 |
| 9 | Cannon-Brookes MichaelDirector, CEO, Co-Founder, 10% Owner | TEAMAtlassian Corp Open-market sale · 10b5-1 plan | SELL | $481K 3,263 sh | Jan 13, 2026 traded Jan 12, 2026 |
| 9 | Flammer Martina M.D.Chief Medical Officer |  INSMINSMED IncOpen-market sale · 10b5-1 plan | SELL | $351K 1,887 sh | Jan 13, 2026 traded Jan 9, 2026 |
| 7 | Wu LeiDirector, Chief Executive Officer, 10% Owner |  GCTGigaCloud Technology IncOpen-market sale · 10b5-1 plan | SELL | $745K 17.7K sh | Jan 13, 2026 traded Jan 9, 2026 |
| 6 | Cannon-Brookes MichaelDirector, CEO, Co-Founder, 10% Owner | TEAMAtlassian Corp Open-market sale · 10b5-1 plan | SELL | $65K 450 sh | Jan 13, 2026 traded Jan 12, 2026 |
| 6 | Farquhar ScottDirector, 10% Owner | TEAMAtlassian Corp Open-market sale · 10b5-1 plan | SELL | $213K 1,435 sh | Jan 13, 2026 traded Jan 12, 2026 |
| 6 | Patel AnishCHIEF OPERATING OFFICER |  ELVNEnliven Therapeutics, Inc.Open-market sale · 10b5-1 plan | SELL | $6,926 243 sh | Jan 13, 2026 traded Jan 9, 2026 |
| 6 | Cannon-Brookes MichaelDirector, CEO, Co-Founder, 10% Owner | TEAMAtlassian Corp Open-market sale · 10b5-1 plan | SELL | $213K 1,435 sh | Jan 13, 2026 traded Jan 12, 2026 |
| 6 | Farquhar ScottDirector, 10% Owner | TEAMAtlassian Corp Open-market sale · 10b5-1 plan | SELL | $65K 450 sh | Jan 13, 2026 traded Jan 12, 2026 |
| 5 | Majalya Sidney A.SVP, CLO and Secretary |  TNETTRINET GROUP, INC.Open-market sale · 10b5-1 plan | SELL | $48K 775 sh | Jan 13, 2026 traded Jan 9, 2026 |
| 4 | Wu LeiDirector, Chief Executive Officer, 10% Owner | GCTGigaCloud Technology Inc Open-market sale · 10b5-1 plan | SELL | $96K 2,265 sh | Jan 13, 2026 traded Jan 9, 2026 |
| 4 | Wu LeiDirector, Chief Executive Officer, 10% Owner | GCTGigaCloud Technology Inc Open-market sale · 10b5-1 plan | SELL | $392K 9,059 sh | Jan 13, 2026 traded Jan 12, 2026 |
| 4 |  Dines DanielDirector, CEO and Chairman, 10% Owner |  PATHUiPath, Inc.Open-market sale · 10b5-1 plan | SELL | $773K 45.0K sh | Jan 13, 2026 traded Jan 13, 2026 |
| 4 | Wu LeiDirector, Chief Executive Officer, 10% Owner | GCTGigaCloud Technology Inc Open-market sale · 10b5-1 plan | SELL | $703K 16.8K sh | Jan 13, 2026 traded Jan 13, 2026 |
| 4 | Lee JanetGC & Corporate Secretary |  SNPSSYNOPSYS INCOpen-market sale · 10b5-1 plan | SELL | $133K 250 sh | Jan 13, 2026 traded Jan 12, 2026 |
| 4 | Wu LeiDirector, Chief Executive Officer, 10% Owner | GCTGigaCloud Technology Inc Open-market sale · 10b5-1 plan | SELL | $303K 6,841 sh | Jan 13, 2026 traded Jan 12, 2026 |
| 3 | Farquhar ScottDirector, 10% Owner | TEAMAtlassian Corp Open-market sale · 10b5-1 plan | SELL | $25K 169 sh | Jan 13, 2026 traded Jan 12, 2026 |